Extended release oral dosage composition

  • US 6,709,676 B2
  • Filed: 06/19/2002
  • Issued: 03/23/2004
  • Est. Priority Date: 12/20/1999
  • Status: Expired due to Term
First Claim
Patent Images

1. A bilayer solid composition comprising (1) a first layer comprising an anti-allergic effective amount of desloratadine and a desloratadine-protective amount of a pharmaceutically acceptable water insoluble basic calcium, magnesium or aluminum salt, or of a desloratadine-protective amount of at least one pharmaceutically acceptable antioxidant;

  • and (2) a second layer comprising an effective amount of pseudoephedrine or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable excipient, and optionally, a desloratadine-protective amount of at least one pharmaceutically acceptable antioxidant.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×